Abstract

The kidney is critical in the long‐term control of blood pressure, and renal inflammation has been linked to the progression of hypertension. Previous experiments have shown a sex difference in protein excretion and the renal immune cell profile: male SHRs have greater indices of renal injury and more pro‐hypertensive renal T helper17 cells (Th17) while females had more BP‐lowering T regulatory cells (Tregs). Male and female SHR were randomized to receive tap water (vehicle) or the BP‐lowering drugs, hydrochlorothiazide and reserpine, in drinking water from 5 to 12 weeks of age. BP was measured by tail cuff, and kidneys were isolated for flow cytometric analysis of T cells. Treatment attenuated age‐related increases in BP in males (174±4 vs. 137±4 mmHg, p<0.05) and females (132±4 vs 161±1 mmHg, p<0.05). However, treatment did not significantly change metabolic parameters, urinary electrolyte excretion (Na+, K+, Cl‐) or urinary protein excretion in either sex. In contrast, although attenuation of the development of hypertension did not significantly change the renal T cell profile in male SHR, females exhibited a decrease in renal Tregs (p=0.0091) and Th17 (p=0.0203) counts which abolished the sex differences observed in the renal T cell profile of vehicle‐treated rats.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call